1. Zhang, Yingfan, Huang, Haoxuan, Liu, Peikun, Xie, Yuanyang. . NFYB increases chemosensitivity in glioblastoma by promoting HDAC5-mediated transcriptional inhibition of SHMT2. In Journal of neuropathology and experimental neurology, 82, 911-920. doi:10.1093/jnen/nlad073. https://pubmed.ncbi.nlm.nih.gov/37742129/
2. Fang, Zejun, Gong, Chaoju, Yu, Songshan, Zhang, Xiaomin, Liu, Hong. 2017. NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. In Cancer letters, 415, 58-72. doi:10.1016/j.canlet.2017.11.040. https://pubmed.ncbi.nlm.nih.gov/29203250/
3. Liu, Pulin, Xing, Naifei, Xiahou, Zhikai, Lin, Zhiheng, Zhang, Junlong. 2024. Unraveling the intricacies of glioblastoma progression and recurrence: insights into the role of NFYB and oxidative phosphorylation at the single-cell level. In Frontiers in immunology, 15, 1368685. doi:10.3389/fimmu.2024.1368685. https://pubmed.ncbi.nlm.nih.gov/38510250/
4. Feng, Lili, Xu, Xiaofang, Zhao, Keke. 2021. NFYB potentiates STK33 activation to promote cisplatin resistance in diffuse large B-cell lymphoma. In Leukemia research, 111, 106708. doi:10.1016/j.leukres.2021.106708. https://pubmed.ncbi.nlm.nih.gov/34536775/
5. Gurtner, Aymone, Manni, Isabella, Piaggio, Giulia. 2016. NF-Y in cancer: Impact on cell transformation of a gene essential for proliferation. In Biochimica et biophysica acta. Gene regulatory mechanisms, 1860, 604-616. doi:10.1016/j.bbagrm.2016.12.005. https://pubmed.ncbi.nlm.nih.gov/27939755/
6. Lin, Shudai, Luo, Wei, Jiang, Mingya, Zhang, Li, Zhang, Xiquan. 2017. Chicken CCDC152 shares an NFYB-regulated bidirectional promoter with a growth hormone receptor antisense transcript and inhibits cells proliferation and migration. In Oncotarget, 8, 84039-84053. doi:10.18632/oncotarget.21091. https://pubmed.ncbi.nlm.nih.gov/29137403/
智鼠故事 
